Aakash Desai Associate Director of Phase 1 and Precision Oncology Program at UAB O’Neal Comprehensive Cancer Center shared a post on LinkedIn:
“Real-World Data on Immunotherapy Use in Early NSCLC.
Pleased to share the real-world data on immunotherapy use in early-stage NSCLC presented by our team UAB O’Neal Comprehensive Cancer Center and collaborators at Flatiron Health at ХWCLC24!
Key findings:
- Real-world insights on distant metastasis-free survival in early NSCLC patients
- Analysis of metastasis sites and the need for improved biomarker testing highlighted
Exciting work that underscores the importance of translating clinical research into everyday practice.”
Source: Aakash Desai/LinkedIn